Idorsia Ltd (IDIA) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.023x

Based on the latest financial reports, Idorsia Ltd (IDIA) has a cash flow conversion efficiency ratio of 0.023x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CHF-26.63 Million ≈ $-33.67 Million USD) by net assets (CHF-1.18 Billion ≈ $-1.49 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Idorsia Ltd (IDIA) balance sheet quality index to measure how much of total assets are equity-financed.

Idorsia Ltd - Cash Flow Conversion Efficiency Trend (2016–2025)

This chart illustrates how Idorsia Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check IDIA cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.

Idorsia Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Idorsia Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
PC Jeweller Limited NSE:PCJEWELLER	0.005x
GuangYuYuan Chinese Herbal Medicine Co Ltd SHG:600771	0.065x
Shanghai Action Education Technology CO.LTD. SHG:605098	N/A
Guangxi Wuzhou Zhongheng Group Co Ltd SHG:600252	-0.012x
Motic Xiamen Electric Group Co Ltd SHE:300341	0.010x
Sopharma AD WAR:SPH	-0.018x
Suzhou Shijia Science & Technology Inc SHE:002796	-0.031x
Indocement Tunggal Prakarsa JK:INTP	0.020x

Annual Cash Flow Conversion Efficiency for Idorsia Ltd (2016–2025)

The table below shows the annual cash flow conversion efficiency of Idorsia Ltd from 2016 to 2025. For the full company profile with market capitalisation and key ratios, see Idorsia Ltd stock valuation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CHF-1.14 Billion ≈ $-1.44 Billion	CHF-153.23 Million ≈ $-193.72 Million	0.135x	-55.88%
2024-12-31	CHF-1.21 Billion ≈ $-1.53 Billion	CHF-370.23 Million ≈ $-468.07 Million	0.305x	-52.98%
2023-12-31	CHF-968.72 Million ≈ $-1.22 Billion	CHF-629.30 Million ≈ $-795.60 Million	0.650x	-50.02%
2022-12-31	CHF-660.96 Million ≈ $-835.63 Million	CHF-859.11 Million ≈ $-1.09 Billion	1.300x	+122.96%
2021-12-31	CHF104.20 Million ≈ $131.74 Million	CHF-589.89 Million ≈ $-745.79 Million	-5.661x	-808.88%
2020-12-31	CHF585.48 Million ≈ $740.21 Million	CHF-364.67 Million ≈ $-461.04 Million	-0.623x	+77.85%
2019-12-31	CHF164.35 Million ≈ $207.78 Million	CHF-462.04 Million ≈ $-584.14 Million	-2.811x	-424.02%
2018-12-31	CHF657.62 Million ≈ $831.42 Million	CHF-352.82 Million ≈ $-446.06 Million	-0.537x	-515.46%
2017-12-31	CHF739.51 Million ≈ $934.94 Million	CHF95.50 Million ≈ $120.73 Million	0.129x	+124.91%
2016-12-31	CHF507.97 Million ≈ $642.21 Million	CHF-263.34 Million ≈ $-332.93 Million	-0.518x	--

About Idorsia Ltd

SW:IDIA Switzerland Biotechnology

Market Cap

$1.95 Billion

CHF1.54 Billion CHF

Market Cap Rank

#8781 Global

#119 in Switzerland

Share Price

CHF6.06

Change (1 day)

+5.76%

52-Week Range

CHF2.43 - CHF6.89

All Time High

CHF33.62